SEC Form 4 · accession 0001127602-18-010264
GILEAD SCIENCES, INC. · GILD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nicholas G Moore
Director
Period of report
Mar 1, 2018
Accepted (ET)
Mar 5, 2018 · 8:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000882095
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Mar 1, 2018 | M | 178 | $0.00 | A | 12,233 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Phantom StockF2,F1,F3 | $0.00 | Mar 1, 2018 | M | 178 | D | — | — | Common Stock | 178 | 27,170 | D |
Explanation of responses
- F1Each share of phantom stock is the economic equivalent of one share of Gilead common stock, except fractional shares are paid in cash.
- F2An aggregate of 178.180639 shares were reported in Table II when reporting person acquired the phantom shares. The fractional share of 0.180639 was paid out in cash in connection with the conversion into shares of common stock.
- F3The shares of phantom stock are fully vested and, at the election of the reporting person, become payable in common stock at a later date identified by the reporting person.